J. Goldman & Co’s GE HealthCare GEHC Stock Holding History

J. Goldman & Co’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-81,455	Closed	-$6.68M	–	737
2025 Q4	$6.68M	Buy	+81,455	New	+$6.35M	0.18%	160

Other funds holding GEHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

J. Goldman & Co's GEHC Position: Q1 2026 in Review

J. Goldman & Co sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 81,455 shares — an estimated $6.68M sold.

J. Goldman & Co first reported a position in GEHC in Q4 2025 and held it in 1 quarter. The position peaked at $6.68M in Q4 2025. 1,273 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

J. Goldman & Co reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
J. Goldman & Co sold 81,455 GE HealthCare shares in Q1 2026, an estimated $6.68M.
J. Goldman & Co first reported a position in GE HealthCare in Q4 2025 and held it in 1 quarter.
J. Goldman & Co's GE HealthCare position peaked at $6.68M in Q4 2025.
1,273 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.